- Home
- RLGT vs AMRN Comparison
RLGT vs AMRN Comparison
Compare RLGT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | AMRN |
|---|---|---|
| Founded | 2001 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.3M | 304.6M |
| IPO Year | 2006 | 1998 |
Fundamental Metrics
Financial Performance| Metric | RLGT | AMRN |
|---|---|---|
| Price | $7.88 | $14.67 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | $8.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 103.5K | 36.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | 55.00 |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $902,696,000.00 | $181,104,000.00 |
| Revenue This Year | $2.13 | N/A |
| Revenue Next Year | $5.18 | $1.26 |
| P/E Ratio | $56.50 | ★ N/A |
| Revenue Growth | 12.49 | ★ 39.22 |
| 52 Week Low | $5.61 | $8.84 |
| 52 Week High | $8.50 | $20.90 |
Technical Indicators
Market Signals| Indicator | RLGT | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 68.68 | 46.99 |
| Support Level | $5.86 | $14.39 |
| Resistance Level | $8.50 | $16.95 |
| Average True Range (ATR) | 0.20 | 0.53 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 87.08 | 63.90 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.